Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Amarantus Bioscience Holdings (AMBS) Message Board

In the event that creditors and certain other part

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 30070
(Total Views: 434)
Posted On: 06/20/2017 12:31:38 PM
Avatar
Posted By: jamiejaytrader
Re: All Aboard #24996
Quote:
In the event that creditors and certain other parties decline to participate in the planned restructuring of liabilities to be developed by Amarantus' management under the supervision of the Board, and to execute such releases as may be required in connection with such restructuring, SeD Biomedical reserves the right to terminate the LOI. "



I recall reading this but i read it as boilerplate language but i can see you how this can also be interpreted as a threath now.
Thanks for pointing this out to me.

Quote:
You don't know this for certain. The preferreds made the release of their liens contingent on a number of things. One was that SeD inject an asset into AMBS. They also required that AMBS hire (and pay for) a valuation firm to value the asset or assets that SeD puts in. The minimum acceptable value was $12.5M. But we have seen no evidence that they have hired a valuation firm or have any money to pay them.



I had to do some digging on where i read about the $12.5m figure but i found the part i was referring to:

Its in the 8K on 3/28/17.

http://ir.amarantus.com/all-sec-filings/conte...002902.pdf

Quote:
The strategies for the AMBS, AVDX and Cutanogen will only be implemented upon the signing of the LOI and the
cooperative support of the secured debt holders. Funding would be pursued immediately following the signing of the LOI.
Successful funding for any of the two entities at the following levels would trigger the unconditional release of all assets of
AMBS by the debt holders: $2.5 million for Cutanogen, $1.5 million for AVDX, or $1.5 million for AMBS, accompanied
by an asset injected by SED Biomedical into AMBS that is valued by a nationally recognized firm at a minimum of $12.5
million.




I read that part the way i implied it to you in my other message.
So what your saying is that i misread that and they still need to valuate?
I understood it as they already have one asset valued at $12.5m.

If i misread it, then i stand corrected

Thanks for your help!


(1)
(0)




Amarantus Bioscience Holdings (AMBS) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us